JSL
MRNA icon

JT Stratford LLC’s Moderna MRNA Stock Holding History

JT Stratford LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,710
Closed -$322K – 307
2024
Q2 		$322K Sell
2,710
-37
-1% -$4.68K 0.06% 223
2024
Q1 		$293K Buy
+2,747
New +$277K 0.06% 225
2023
Q1 		– Sell
-1,697
Closed -$305K – 234
2022
Q4 		$305K Sell
1,697
-5,603
-77% -$916K 0.1% 183
2022
Q3 		$863K Buy
+7,300
New +$1.11M 0.31% 77
2022
Q1 		– Sell
-1,929
Closed -$490K – 223
2021
Q4 		$490K Sell
1,929
-2,062
-52% -$603K 0.13% 138
2021
Q3 		$1.54M Sell
3,991
-788
-16% -$291K 0.47% 57
2021
Q2 		$1.12M Sell
4,779
-291
-6% -$52K 0.36% 78
2021
Q1 		$664K Sell
5,070
-407
-7% -$59K 0.23% 99
2020
Q4 		$572K Buy
5,477
+2,034
+59% +$206K 0.21% 92
2020
Q3 		$244K Sell
3,443
-754
-18% -$52.6K 0.11% 131
2020
Q2 		$269K Buy
+4,197
New +$230K 0.14% 125

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JT Stratford LLC's MRNA Position: Q3 2024 in Review

JT Stratford LLC sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,710 shares — an estimated $322K sold.

JT Stratford LLC first reported a position in MRNA in Q2 2020 and held it in 11 quarters. The position peaked at $1.54M in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • JT Stratford LLC reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • JT Stratford LLC sold 2,710 Moderna shares in Q3 2024, an estimated $322K.
  • JT Stratford LLC first reported a position in Moderna in Q2 2020 and held it in 11 quarters.
  • JT Stratford LLC's Moderna position peaked at $1.54M in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on JT Stratford LLC's 13F filing for Q3 2024, filed 14 Nov 2024.